Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial
暂无分享,去创建一个
A. Dicko | O. Doumbo | J. Ouédraogo | A. Djimde | S. Sirima | A. Beavogui | I. Sagara | A. Togo | S. Borrmann | C. Sutherland | S. Duparc | I. Zongo | M. Diallo | I. Soulama | Edith C. Bougouma | S. Picot | A. Björkman | J. Gil | A. Diarra | I. Borghini-Fuhrer | M. Diarra | O. Traore | Souleymane Dama | N. Diallo | Aliou Traoré | S. Koumare | Samba Coumare | Aissata Barry | S. M. Ouattara | D. Kargougou | A. Coulibaly | Y. Compaoré | Bakary Fofana | H. Maiga | Niawanlou Dara | H. Niangaly | B. Sangare | M. Coulibaly | Frederic Nikiema | A. Somé | Harouna Soré | I. Théra | Amadou Bamadio | Moussa Djimdé | M. Alhousseini | S. Goita | Hamadoun Diakité | M. Keita | Jangsik Shin | Robert M. Miller | Issaka Abdoul Habib Issaka Issiaka Isabelle Bakary Aliou Sagara Beavogui Zongo Soulama Borghini-Fuh | D. Camara | Bouran Sidibé | François Dao | M. Kabore | N. Henry | M. Sylla | I. Thera | Francois Dao | Ismaila Thera | A. Béavogui | Harouna Sorè